<DOC>
	<DOCNO>NCT00972673</DOCNO>
	<brief_summary>This randomize , double blind , placebo control , parallel-group , repeat dose study investigate safety , tolerability , pharmacokinetics pharmacodynamics inhale dose novel dry powder device healthy Japanese male subject .</brief_summary>
	<brief_title>A Study GW685698X Healthy Japanese Male Subjects</brief_title>
	<detailed_description />
	<criteria>Japanese healthy male subject age 20 64 year age inclusive . Healthy subject define individual free clinically significant illness disease determine medical history , physical examination , laboratory study , test . Body weight ≥ 50kg BMI within range 18.525.0kg/m2 inclusive . Nonsmokers ( never smoke smoking &gt; 6 month &lt; 10 pack year history ( Pack year = ( cigarette per day smoked/20 ) x number year smoke ) ) Clinical laboratory test data obtain screen meet following : AST ( GOT ) , ALT ( GPT ) , totalbilirubin : upper limit normal range Normal 12lead EGC find screening ; QTc ( B ) interval &lt; 450msec Normal spirometry ( FEV1 ≥ 80 % predict , FEV1/FVC ≥ 70 % ) . Rapid ACTH normal range screening . Capable give write informed consent , include compliance requirement restriction list consent form . Capable use novel dry powder inhaler . The subject clinically relevant abnormality medical examination , vital sign , clinical laboratory test medical history screen medical opinion investigator subject medical history consider eligible inclusion study investigator . The subject allergy drug idiosyncrasy The subject allergy drug hypersensitivity milk protein excipients lactose monohydrate magnesium stearate . T subject currently participate another clinical study postmarketing study subject expose investigational noninvestigational drug device . The subject participate clinical study investigational noninvestigational drug device previous 4 month . The subject history current condition drug abuse alcoholism . History regular alcohol consumption exceed average , 14 drinks/week ( 1 drink = 5 ounce ( 150mL ) wine 350mL beer 1.5 ounce ( 45mL ) 80 proof distil spirit ) within 6 month screening . The subject positive urine drug screening . Use prescription nonprescription drug , include CYP3A/PGP inhibitor , vitamin , herbal dietary supplement ( include St John'sWort ) within 14 day prior first dose study medication . The subject know allergy hypersensitivity corticosteroid . The subject know allergy hypersensitivity synthetic ACTH The subject history asthma childhood respiratory disorder . The subject permanent ( occasional study ) nightshift worker* . * Permanent night shift worker define person continue life get 12:00 day time eat supper 0:00 midnight seven day usually . The subject positive syphilis , HBs antigen , HCV antibody , HIV antibody , HTLV1 antibody . The subject donate unit blood `` &gt; 400mL '' within previous 4 month `` &gt; 200mL '' within previous 1 month .</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>